PRRX2
Basic information
Region (hg38): 9:129665647-129722674
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRRX2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 25 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 25 | 0 | 0 |
Variants in PRRX2
This is a list of pathogenic ClinVar variants found in the PRRX2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-129665876-C-A | not specified | Uncertain significance (Jun 27, 2022) | ||
9-129665900-C-G | not specified | Uncertain significance (Jan 31, 2024) | ||
9-129665917-C-T | not specified | Uncertain significance (Oct 16, 2024) | ||
9-129665922-C-A | not specified | Uncertain significance (Jul 19, 2022) | ||
9-129665931-C-G | not specified | Uncertain significance (Aug 02, 2021) | ||
9-129666006-G-A | not specified | Uncertain significance (May 24, 2023) | ||
9-129666013-T-G | not specified | Uncertain significance (Nov 12, 2021) | ||
9-129666043-C-T | not specified | Uncertain significance (Nov 16, 2021) | ||
9-129666058-A-G | not specified | Uncertain significance (Nov 16, 2021) | ||
9-129666066-G-C | not specified | Uncertain significance (Jun 17, 2024) | ||
9-129666072-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
9-129666078-C-T | not specified | Uncertain significance (Oct 05, 2023) | ||
9-129666085-C-G | not specified | Uncertain significance (Aug 14, 2024) | ||
9-129666118-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
9-129719246-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
9-129719263-G-T | not specified | Uncertain significance (Jun 07, 2024) | ||
9-129719264-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
9-129719270-G-T | not specified | Uncertain significance (May 03, 2023) | ||
9-129719278-A-C | not specified | Uncertain significance (Nov 23, 2024) | ||
9-129719288-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
9-129719300-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
9-129719342-A-G | not specified | Uncertain significance (Dec 17, 2023) | ||
9-129719343-G-C | not specified | Uncertain significance (Oct 01, 2024) | ||
9-129719371-C-G | not specified | Uncertain significance (Sep 06, 2022) | ||
9-129719395-A-G | not specified | Uncertain significance (Jan 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PRRX2 | protein_coding | protein_coding | ENST00000372469 | 4 | 56956 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.140 | 0.787 | 125696 | 0 | 9 | 125705 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.477 | 102 | 116 | 0.876 | 0.00000854 | 1597 |
Missense in Polyphen | 40 | 58.413 | 0.68478 | 501 | ||
Synonymous | -0.776 | 54 | 47.2 | 1.14 | 0.00000336 | 537 |
Loss of Function | 1.45 | 2 | 5.75 | 0.348 | 2.45e-7 | 90 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000293 | 0.0000293 |
Ashkenazi Jewish | 0.000106 | 0.0000993 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000552 | 0.0000528 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in the scarless healing of cutaneous wounds during the first two trimesters of development. {ECO:0000269|PubMed:9665387}.;
Recessive Scores
- pRec
- 0.156
Haploinsufficiency Scores
- pHI
- 0.419
- hipred
- Y
- hipred_score
- 0.521
- ghis
- 0.550
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.307
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Prrx2
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; vision/eye phenotype;
Gene ontology
- Biological process
- regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;multicellular organism development
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding